Search Results - "Guiot T"

MC13-0066 ORILAB a functional and molecular imaging corelab for cancer research.

Authors: Belenguer-Querol, L. Guiot, T. Garcia, C. et al.

Source: European Journal of Cancer. Nov2013 Supplement 4, Vol. 49, pS30-S31. 1p.

Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.

Authors: Wimana, Zéna Gebhart, G. Guiot, T. et al.

Source: Molecular Imaging & Biology. Oct2015, Vol. 17 Issue 5, p697-703. 7p.

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.

Authors: Gebhart, G. Lamberts, L. E. Wimana, Z. et al.

Source: Annals of Oncology. Apr2016, Vol. 27 Issue 4, p619-624. 6p. 1 Diagram, 1 Graph.

Optimal power flow of a distribution system based on increasingly tight cutting planes added to a second order cone relaxation.

Authors: Abdelouadoud, S.Y. Girard, R. Neirac, F.P. et al.

Source: International Journal of Electrical Power & Energy Systems. Jul2015, Vol. 69, p9-17. 9p.

P-276 Sex and regorafenib toxicity in refractory colorectal cancer: A safety analysis of the RegARd-C trial.

Authors: Vandeputte, C. Bregni, G. Paraskevas, G. et al.

Source: Annals of Oncology. 2021 Supplement 3, Vol. 32, pS191-S192. 2p.

PO-1677: Quality Volume Histogram concept for personalized radioembolization based on MAA SPECTCT simulation.

Authors: Burghelea, M. Levillain, H. Vanderlinden, B. et al.

Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS922-S922. 1p.

[¹⁷⁷Lu]Lu-PSMA SPECT/CT for early response assessment using quantitative RECIP 1.0.

Authors: Kassas M Devriendt L Manley M et al.

Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2026 Mar; Vol. 53 (4), pp. 2257-2270. Date of Electronic Publication: 2025 Nov 10.

Publication Type: Journal Article

Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

Clinicopathological and molecular predictors of [¹⁸F]FDG-PET disease detection in HER2-positive early breast cancer: RESPONSE, a substudy of the randomized PHERGain trial.

Authors: Llombart-Cussac A Prat A Pérez-García JM et al.

Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (9), pp. 2733-2743. Date of Electronic Publication: 2024 Apr 08.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1619-7089 (Electronic) Linking ISSN: 16197070 NLM ISO Abbreviation: Eur J Nucl Med Mol Imaging Subsets: MEDLINE

Optimal [¹⁸F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain Trial.

Authors: Gebhart G Keyaerts M Guiot T et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 May 01; Vol. 65 (5), pp. 708-713. Date of Electronic Publication: 2024 May 01.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Authors: Mileva M de Vries EGE Guiot T et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2024 Jan 06; Vol. 10 (1), pp. 4. Date of Electronic Publication: 2024 Jan 06.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Myoendothelial feedback in mouse mesenteric resistance arteries is similar between the sexes, dependent on nitric oxide synthase, and independent of TPRV4.

Authors: Looft-Wilson RC Stechmann JK Milenski KG et al.

Source: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2024 Jan 01; Vol. 326 (1), pp. H190-H202. Date of Electronic Publication: 2023 Nov 03.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-1539 (Electronic) Linking ISSN: 03636135 NLM ISO Abbreviation: Am J Physiol Heart Circ Physiol Subsets: MEDLINE

Development and Validation of an ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Authors: Paquier Z Dhont J Guiot T et al.

Source: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2025 May; Vol. 9, pp. e2400207. Date of Electronic Publication: 2025 Apr 30.

Publication Type: Journal Article; Validation Study

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101708809 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4276 (Electronic) Linking ISSN: 24734276 NLM ISO Abbreviation: JCO Clin Cancer Inform Subsets: MEDLINE

Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial.

Authors: Rediti M Fimereli D Mileva M et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Jan 06; Vol. 31 (1), pp. 110-121.

Publication Type: Journal Article

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer.

Authors: Woff E Salvatore L Marmorino F et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Apr; Vol. 63 (4), pp. 549-555. Date of Electronic Publication: 2021 Jul 29.

Publication Type: Journal Article

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Authors: Gombos A Venet D Ameye L et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2022 Mar 16; Vol. 8 (1), pp. 38. Date of Electronic Publication: 2022 Mar 16.

Publication Type: Published Erratum

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Sex and Regorafenib Toxicity in Refractory Colorectal Cancer: Safety Analysis of the RegARd-C Trial.

Authors: Vandeputte C Bregni G Gkolfakis P et al.

Source: Clinical colorectal cancer [Clin Colorectal Cancer] 2021 Dec; Vol. 20 (4), pp. 326-333. Date of Electronic Publication: 2021 Jul 24.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Authors: Gombos A Venet D Ameye L et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2021 Sep 21; Vol. 7 (1), pp. 125. Date of Electronic Publication: 2021 Sep 21.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study.

Authors: Mokhtari A Casale R Salahuddin Z et al.

Source: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Mar 28; Vol. 14 (7). Date of Electronic Publication: 2024 Mar 28.

Publication Type: Journal Article

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101658402 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4418 (Print) Linking ISSN: 20754418 NLM ISO Abbreviation: Diagnostics (Basel) Subsets: PubMed not MEDLINE

Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel.

Authors: Shagera QA Karfis I Sideris S et al.

Source: Clinical nuclear medicine [Clin Nucl Med] 2023 Sep 01; Vol. 48 (9), pp. 775-780. Date of Electronic Publication: 2023 Jun 29.

Publication Type: Journal Article

Journal Info: Publisher: Lippincott Country of Publication: United States NLM ID: 7611109 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-0229 (Electronic) Linking ISSN: 03639762 NLM ISO Abbreviation: Clin Nucl Med Subsets: MEDLINE

Combining ¹⁸F-FDG PET/CT-Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer.

Authors: Woff E Kehagias P Vandeputte C et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2019 Oct; Vol. 60 (10), pp. 1366-1372. Date of Electronic Publication: 2019 Mar 08.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE